Group One Trading
JSPR icon

Group One Trading’s Jasper Therapeutics JSPR Stock Holding History

Group One Trading’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.29K Buy
+19,700
New +$14.7K ﹤0.01% 6514
2025
Q4 		– Sell
-9,100
Closed -$21.7K – 8653
2025
Q3 		$21.7K Buy
9,100
+7,900
+658% +$24K ﹤0.01% 6642
2025
Q2 		$6.66K Buy
+1,200
New +$5.91K ﹤0.01% 6953
2025
Q1 		– Sell
-400
Closed -$8.55K – 7977
2024
Q4 		$8.55K Buy
+400
New +$8.33K ﹤0.01% 6178

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's JSPR Position: Q2 2026 in Review

Group One Trading increased its Jasper Therapeutics (JSPR) stake by 2,152% in Q2 2026, buying an estimated $14.3K and bringing the position to 19,930 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #6504.

Group One Trading first reported a position in JSPR in Q2 2022 and has held it in 9 quarters since. The position peaked at $41.8K in Q3 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Group One Trading held 19,930 shares of Jasper Therapeutics worth $8.39K as of Q2 2026.
  • Group One Trading bought 19,045 Jasper Therapeutics shares in Q2 2026, an estimated $14.3K.
  • Jasper Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6504 holding.
  • Group One Trading first reported a position in Jasper Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • Group One Trading's Jasper Therapeutics position peaked at $41.8K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.